eisai china inc
Eisai Acquires Chinese Generics Company Liaoning TianYi
The acquisition of Liaoning gives Eisai a foothold in China’s generics sector which accounts for 80 percent of the country’s pharmaceutical market.
Eisai Expands Facilities In Suzhou
The expansion of Eisai's manufacturing capabilities at the Suzhou Industrial Park reflects China's growing importance for the Japanese pharmaceutical company.
Eisai To Open New Plant In Suzhou, China
Eisai Co., Ltd. will open a new plant at the Suzhou Industrial Park in Suzhou, Jiangsu, China in the first quarter of 2014.
